Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endomyocardial Fibrosis With End-Stage Heart Failure as a Consequence of a Myeloproliferative Neoplasm With Hypereosinophilia.

The Canadian journal of cardiology - 1 Sept 2018

Strong Christopher, Abecasis João, Afonso Celina, Trabulo Marisa, Gouveia Rosa

Abstract excerpt

Hypereosinophilic syndrome is characterized by an overproduction of eosinophils that infiltrate and damage multiple organs. Cardiac dysfunction occurs frequently and is a main cause of morbidity and mortality. We describe the case of a middle-aged man diagnosed with a myeloproliferative neoplasm associated with hypereosinophilia and treated with imatinib. He was diagnosed with cardiac involvement by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endocardium
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Transplantation

Share to Hypereosinophilic Syndrome

Share to Imatinib Mesylate

Share to mRNA Cleavage and Polyadenylation Factors

Share to Oncogene Proteins, Fusion

Share to Receptor, Platelet-Derived Growth Factor alpha

Source

Identifiers

PMID: 30170680
DOI: 10.1016/j.cjca.2018.05.024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endomyocardial Fibrosis With End-Stage Heart Failure as a Consequence of a Myeloproliferative Neoplasm With Hypereosinophilia.PMID 30170680Read ↗

A case report of right-sided heart failure secondary to JAK2-mutation Loeffler endocarditis.Semantic proximity Read ↗

Hypereosinophilic Syndrome as a Rare Cause of Reversible Biventricular Heart Failure.Semantic proximity Read ↗

Pathophysiology of hypereosinophilia-associated heart diseaseSemantic proximity Read ↗

Imatinib for the treatment of hypereosinophilic syndromes.Semantic proximity Read ↗

Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.Semantic proximity Read ↗

[The heart and the eosinophil].Semantic proximity Read ↗

Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders.Semantic proximity Read ↗

Maintenance therapy with imatinib appears necessary despite molecular remission in FIP1L1-PDGFRA fusion gene positive hypereosinophilic disorder.Semantic proximity Read ↗

Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation status.Semantic proximity Read ↗

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndromeSemantic proximity Read ↗

Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.Semantic proximity Read ↗

BNP as a marker of the heart failure in the treatment of imatinib mesylate.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.